|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/496 | |
| A61P 37/00 |
| (11) | Number of the document | 3028702 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16153335.1 |
| Date of filing the European patent application | 2011-11-22 | |
| (97) | Date of publication of the European application | 2016-06-08 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-12 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 416689 P | 2010-11-23 | US |
| (72) |
ELMORE, Steven, US
SOUERS, Andrew, US
WANG, Li Chun, US
GHAYUR, Tariq, US
PERPER, Stuart J., US
|
| (73) |
AbbVie Ireland Unlimited Company,
70 Sir John Rogerson`s Quay, Dublin 2,
IE
|
| (54) | METHODS OF TREATMENT USING SELECTIVE BCL-2 INHIBITORS |
| METHODS OF TREATMENT USING SELECTIVE BCL-2 INHIBITORS |